Proxy Votes Now

Home › Funds › UBS › UBS US Quality Growth At Reasonable Price Fund

UBS US Quality Growth At Reasonable Price Fund (QGRPX) proxy voting record 2025-2026

Fund family: UBS · Filed by UBS FUNDS (CIK 886244) · SEC series S000068970

Ticker: QGRPX (C000220415)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 327 with, 54 against, 0 abstentions (not counted as with management); 1 split votes are in neither count. Shareholder proposals: 25 FOR, 29 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with UBS as a whole

The same two figures as UBS’s manager page (22,602 ballot items across 14 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsUBSItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)89.2%31669.1%20,107
Backed environmental and social shareholder proposals at US companiesn/a3527.4%350

Where this fund voted differently from most UBS funds

Each ballot item this fund voted is set against the votes of the other UBS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most UBS funds on all 105 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 99.2% of this fund’s 381 such votes could be given a sector; the other 3 (0.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Technology1503221.3%
Consumer Discretionary1051615.2%
Health Care5235.8%
Finance4237.1%
Industrials2400.0%
Telecommunications500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2570
Audit-related270
Say-on-Pay260
Corporate Governance2212
Other Social Issues2019
Environment or Climate1212
Compensation82
Shareholder Rights and Defenses65
Human Rights or Human Capital/workforce44

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Microsoft CorporationDecember 5, 2025$48M216
NVIDIA CorporationJune 24, 2026$35M164
Apple Inc.February 24, 2026$35M121
Meta Platforms, Inc.May 27, 2026$27M228
Eli Lilly and CompanyMay 4, 2026$21M102
Amazon.com, Inc.May 20, 2026$19M174
Broadcom Inc.April 20, 2026$16M100
Alphabet Inc.June 5, 2026$16M2310

Notable votes against management

MeetingCompanyProposalFundMgmt
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding dual class capital structure. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalForAgainst
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalForAgainst

Search this fund’s votes by company

382 ballot items at 28 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, UBS US Quality Growth At Reasonable Price Fund (QGRPX) voted at 28 shareholder meetings of 28 companies, on 382 ballot items in all. Where management made a recommendation, the fund followed it on 85.8% of the items and voted against it 54 times. Its most frequent area of disagreement was other social issues (19 of its votes against management). It voted FOR 46.3% of the 54 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than UBS's funds as a whole (89.2% against 69.1%). It voted the same way as most UBS funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of UBS’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.